Intelligent bio solutions expands middle east market reach with arabic integration in drug screening system

New york, march 31, 2025 (globe newswire) -- intelligent bio solutions inc. (nasdaq: inbs) (“inbs” or the “company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has integrated arabic as the second international language to its intelligent fingerprinting drug screening system as part of the company's multilingual upgrade. the addition of arabic follows inbs's previously announced expansion plans in the middle east in early 2025, through its partnership with ivy diagnostics.
INBS Ratings Summary
INBS Quant Ranking